V5 Diagnostic Ultrasound System, H5 Diagnostic Ultrasound System, XV5 Diagnostic Ultrasound System, XH5 Diagnostic Ultrasound System, V4 Diagnostic Ultrasound System, H4 Diagnostic Ultrasound System, XV4 Diagnostic Ultrasound System, XH4 Diagnostic Ultrasound System

Samsung Medison's V/H/XV/XH series are mobile, software-controlled diagnostic ultrasound systems that leverage diverse imaging modes and AI-assisted features to enhance image analysis and measurement for a broad range of clinical applications. These systems' safety and effectiveness were validated through extensive non-clinical testing, demonstrating substantial equivalence to existing devices.

Samsung Medison Co., Ltd. has developed a series of mobile, software-controlled diagnostic ultrasound systems, including models V5, H5, XV5, XH5, V4, H4, XV4, and XH4. These systems are designed for comprehensive general diagnostic imaging and fluid flow analysis across a wide range of clinical specialties. Their intended use spans fetal/obstetrics, abdominal, gynecology, cardiac, small organ, and vascular imaging, catering to trained healthcare professionals in diverse settings such as hospitals and private practices. The devices have been determined to be substantially equivalent to existing market systems, indicating their adherence to established safety and performance benchmarks.The scientific basis of these systems lies in their ability to generate detailed images and data through various ultrasound modes, including 2D, Color Doppler, Power Doppler, M-mode, Pulsed Wave Doppler, Continuous Wave Doppler, Tissue Doppler Imaging, ElastoScan, 3D/4D, and MV-Flow. A key technological advancement is the integration of AI-assisted features like BiometryAssist, HeartAssist, ViewAssist, UterineAssist, and NerveTrack, which leverage artificial intelligence to enhance image analysis accuracy and automate measurements. The methodology for validating the systems' safety and effectiveness involved extensive non-clinical testing, covering critical areas such as acoustic output, biocompatibility, software functionality, cleaning protocols, and electrical and mechanical safety, with specific validation performed for the integrated AI components, thereby obviating the need for further human clinical trials.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific clinical scenarios demonstrate the most significant improvement in diagnostic accuracy or workflow efficiency when utilizing the AI-assisted features compared to traditional methods?; Given the "substantial equivalence" finding, what unique technological advancements or novel applications do these specific Samsung Medison models offer beyond their predecessors?; Are there any long-term data or post-market surveillance plans in place to assess the real-world performance and reliability of the AI algorithms, particularly concerning potential biases or variations across diverse patient populations?; How do the various advanced imaging modes (e.g., ElastoScan, MV-Flow) contribute to specific clinical diagnoses, and are there particular areas where one mode offers a distinct advantage over others?; What are the training requirements or certification processes recommended by Samsung Medison for healthcare professionals to optimally utilize the advanced and AI-assisted functionalities of these systems?